← Registry tracker

Open Targets

Drug target discovery and prioritisation platform

View in the Claude registry
Integration details

Description

This MCP provides a purpose-built interface and instructions to access and interpret the data and analyses in the Open Targets Platform. The Open Targets Platform is a comprehensive tool that supports systematic identification and prioritisation of potential therapeutic drug targets, integrating publicly available datasets to build and score target-disease associations. It also integrates relevant annotation information about targets, diseases/phenotypes, drugs, variants, GWAS and molecular QTL studies, and credible sets, as well as their most relevant relationships.

Integration type
Connector
Verification status
Verified connector
Platform
Claude
Category
Data & Analytics

The broad Category that contains the Primary Subcategory.

Primary Subcategory
Biomedical & Pharma Research Intelligence

The Primary Subcategory used for this profile’s headline score.

Secondary Subcategories
None listed

Other Subcategories where the Integration is listed.

Access
No account required
First tracked
2026-01-12
Tool count
4
Geography
US

Get alerts for Open Targets

Get updates when Open Targets’s Discoverability Score or category rank changes.

Claude Discoverability Score

Live · refreshed daily. Last refreshed

Open Targets in Biomedical & Pharma Research Intelligence

0/100
Invisible

#10of 19competitors

Shown to buyers in 0.0% of contested Runs.

What we measure

One core score. Three important factors to discoverability.

  • Picked

    · 0/100
    Sets the score
  • Found

    · 0/100
    Diagnostic
  • Positioned

    · 0/100
    Diagnostic

What a score of 0 means

Claude did not find Open Targets in search, show it to users, or invoke it.

1Not found by ClaudeFound 0/100
2Not shown to usersPicked 0/100

OpenTargets organic discovery report

Get your full discovery report

See how OpenTargets appears in Biomedical & Pharma Research Intelligence, where it ranks, and how it compares with the wider Claude Connector ecosystem.

01

Your snapshot

OpenTargets's score and Biomedical & Pharma Research Intelligence position

02

Industry report

State of Agent Discovery

30-day industry report

No spam. Unsubscribe at any time.

Primary Subcategory
#10 of 19ranked by public Discoverability Score
Primary Subcategory
1AdisInsight100/100
2Clinical Trials100/100
3Amass Connector92/100
4Maven Bio54/100
5Boltz API0/100
10Open Targets0/100
Recommended guideHow to get your Claude Connector organically discoveredFollow the practical steps agents use to find, shortlist, and choose your Connector.Read guide
Tools

4 tools agents can invoke

Open Targets FAQ
How do I improve a Verified connector's discoverability?

The levers are the listing surface agents actually read: names, descriptions, keywords, tool metadata, and registry health. Which lever matters depends on where discovery breaks, which is what continuous measurement shows.

What are Open Targets alternatives on Claude?

As of 2026-09-29, Open Targets competes with AdisInsight, Clinical Trials, Amass Connector, Maven Bio, Boltz API, Cortellis CMC Intelligence, EDEN by Basecamp Research, ICD-10 Codes, Inductive Bio, Synthesize Bio, Convoke, Cortellis Competitive Intelligence, DocCheck Flexikon, DocNexus Advanced Search MCP, mcp.gosset.ai, OFF-X Safety Assistant, PubCrawl, Rhizome AI in Claude Biomedical & Pharma Research Intelligence, ranked by public Discoverability Score.

Where does Open Targets rank in Biomedical & Pharma Research Intelligence on Claude?

As of 2026-09-29, Open Targets ranks #10 of 19 in Claude Biomedical & Pharma Research Intelligence with a Discoverability Score of 0/100 (Invisible).

Where is this profile measured?

This profile uses the geography attached to the latest public registry snapshot: US. Locale tags are intentionally omitted.